Edginton O, George M, Bandara C, Johnston M, Rao A, Howse M, Ridgway D, Goldsmith P
University of Liverpool, UK.
Liverpool University Hospitals NHS Foundation Trust, UK.
Ann R Coll Surg Engl. 2025 Jul;107(6):403-410. doi: 10.1308/rcsann.2024.0062. Epub 2024 Oct 8.
In 2019, a new kidney offering scheme was launched in the United Kingdom, aiming to better match estimated patient survival and graft life expectancy. The scheme's impact on older patients undergoing kidney transplantation (KT) is unknown. This study aims to compare the outcomes of older adult KT recipients before and after introduction of the 2019 scheme.
A retrospective observational cohort study of older adults who underwent KT was undertaken. Group 1 were transplanted between 1 September 2017 and 31 August 2019 (2006 allocation scheme) and group 2 between 1 September 2019 and 31 August 2021 (2019 offering scheme). An older adult was any person ≥60 years old at the time of KT. Univariable binary logistic regression analysis was performed to determine odds ratios (OR) and 95% confidence intervals (CI).
There were 107 older adult deceased donor KT recipients, 62 from group 1 and 45 from group 2. Median age at transplantation was 68 (interquartile range [IQR] 62-71) and 67 (IQR 64-73) years, respectively. Univariable analysis showed that re-intervention (OR 6.486, 95% CI 1.306-32.216, = 0.022) and critical care admission (OR 5.619, 95% CI 1.448-21.812, = 0.013) were significantly more likely in group 2. Group 2 recipients were significantly more likely to have a level 4 human leucocyte antigen (HLA) mismatch (OR 4.667, 95% CI 1.640-13.275, = 0.004) and to have undergone previous KT (OR 4.691, 95% CI 1.385-15.893, = 0.013).
The introduction of the 2019 offering scheme was associated with re-intervention and critical care admission for older KT recipients. We also observed less-favourable HLA matches but more KT in difficult-to-match groups.
2019年,英国推出了一项新的肾脏分配计划,旨在使患者的预估生存期与移植肾预期寿命更好地匹配。该计划对接受肾移植(KT)的老年患者的影响尚不清楚。本研究旨在比较2019年该计划实施前后老年肾移植受者的结局。
对接受肾移植的老年人进行了一项回顾性观察队列研究。第1组在2017年9月1日至2019年8月31日期间接受移植(2006年分配方案),第2组在2019年9月1日至2021年8月31日期间接受移植(2019年分配方案)。老年患者定义为肾移植时年龄≥60岁的任何人。进行单变量二元逻辑回归分析以确定比值比(OR)和95%置信区间(CI)。
共有107例老年尸体供肾肾移植受者,第1组62例,第2组45例。移植时的中位年龄分别为68岁(四分位间距[IQR]62 - 71)和67岁(IQR 64 - 73)。单变量分析显示,第2组再次干预(OR 6.486,95% CI 1.306 - 32.216,P = 0.022)和入住重症监护病房(OR 5.619,95% CI 1.448 - 21.812,P = 0.013)的可能性显著更高。第2组受者有4级人类白细胞抗原(HLA)错配(OR 4.667,95% CI 1.640 - 13.275,P = 0.004)以及既往接受过肾移植(OR 4.691,95% CI 1.385 - 15.893,P = 0.013)的可能性也显著更高。
2019年分配方案的实施与老年肾移植受者的再次干预和入住重症监护病房有关。我们还观察到HLA匹配情况较差,但在难以匹配的群体中肾移植更多。